Magnitude of Osteoarthritis disadVantage on pEoples liveS

Osteoarthritis Clinical Trial

— MOVES  

Official title:

Magnitude of Osteoarthritis disadVantage on pEoples liveS

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01423097
• Other study ID #: NIS-RPO-XXX-2011/2
• Status: Completed
• Phase: N/A
• First received: August 24, 2011
• Last updated: October 9, 2012
• Start date: September 2011
• Est. completion date: November 2011

Study information

• Verified date: October 2012
• Source: AstraZeneca
• Contact: n/a
• Is FDA regulated: No
• Health authority: Portugal: Data Protection National Committee
• Study type: Observational

Clinical Trial Summary

Estimate the prevalence of self-reported osteoarthritis and its characterization in adults over 45 years of age:

• Characterization of self-reported patients with OA (socio-demographic, comorbidities, VAS for intensity of pain)

• Characterization of OA diagnosis in patients with self-reported OA

• Impact of self-reported OA in the working abilities, quality of life and functionality (SF-12 v2.0)

• Characterization of treatment approaches (therapeutic and non-therapeutic) for self-reported patients with OA

• Patient perception of impact of OA in its life and importance given to disease

Description:

Magnitude of Osteoarthritis disadvantage on peoples lives.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1015
• Est. completion date: November 2011
• Est. primary completion date: November 2011
• Accepts healthy volunteers: No
• Gender: Both
• Age group: 45 Years and older

Eligibility

Inclusion Criteria:

• Adults over 45 years old with self-reported osteoarthritis

Exclusion Criteria:

• NA

Study Design

Observational Model: Ecologic or Community, Time Perspective: Cross-Sectional

Related Conditions & MeSH terms

• Osteoarthritis

Locations

Country	Name	City	State
Portugal	Research Site	Queluz Baixo	Barcarena

Sponsors (1)

Lead Sponsor	Collaborator
AstraZeneca

Country where clinical trial is conducted

Portugal, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Estimate the prevalence of self-reported osteoarthritis (OA) in adults over 45 years of age by direct interview.		Single interview at the only one patient contact	No
Secondary	Characterization of self-reported patients with OA by collecting socio-demographic information through direct interview.		Single interview at the only one patient contact	No
Secondary	Characterization of self-reported patients with OA by collecting comorbidities information through direct interview.		Single interview at the only one patient contact	No
Secondary	Characterization of self-reported patients with OA by collecting information for intensity of pain through direct interview.		Single interview at the only one patient contact	No
Secondary	Characterization of OA diagnosis in patients with self-reported OA by direct interview.		Single interview at the only one patient contact	No
Secondary	Impact of self-reported OA in the working abilities, quality of life and functionality using Questionnaire SF-12 v2.0		Single interview at the only one patient contact	No
Secondary	Patient perception of impact of OA in its life and importance given to disease by direct interview.		Single interview at the only one patient contact	Yes